Differing Influences of Virus Burden and Immune Activation on Disease Severity in Secondary Dengue‐3 Virus Infections
Abstract
Dengue hemorrhagic fever (DHF), the most severe form of illness following infection with a dengue virus, is characterized by plasma leakage, thrombocytopenia, and hepatic inflammation. The interrelationships among virus burden, immune activation, and development of DHF were examined in 54 children with secondary dengue-3 virus infections participating in a prospective, hospital-based study. DHF was associated with higher mean plasma viremia early in illness and earlier peak plasma interferon-gamma levels. Maximum plasma viremia levels correlated with the degree of plasma leakage and thrombocytopenia. Maximum plasma levels of interleukin (IL)-10 and soluble tumor necrosis factor receptor-II correlated with the degree of thrombocytopenia, independently of viremia levels. Hepatic transaminase elevation correlated with plasma soluble IL-2 receptor levels and not with viremia levels. Quantitative differences in virus burden and host immune responses, and the timing of type 1 cytokine responses, have differing influences on the severity of disease manifestations during secondary dengue-3 virus infections.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Serum concentrations of IFN-alpha, IFN-gamma, IL-10, and TNF receptors are elevated in the early phase of dengue and remain elevated until defervescence occurs.
“Serum concentrations of IFN-␣, IFN-␥, IL-10, and TNF receptors are elevated in this early phase and remain elevated until defervescence occurs (86).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Rapid and simple method for purification of nucleic acids
Boom, R., Sol, C. J. A., Salimans, M. M. M., Jansen, C. L., Dillen, P. M. E. W., & van der Noordaa, J. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.3.495-503.1990 · Cited by 5,273 · see citing works
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,394 · see citing works
Techniques for Hemagglutination and Hemagglutination-Inhibition with Arthropod-Borne Viruses
Clarke, D. H., & Casals, J. (1958) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1958.7.561 · Cited by 2,050 · see citing works
Lanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,820 · see citing works
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,633 · see citing works
Self-citationSoluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
Rubin, L. A., Kurman, C. C., Fritz, M. E., Biddison, W. E., Boutin, B., Yarchoan, R., & Nelson, D. L. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3172 · Cited by 1,146 · see citing works
A Prospective Study of Dengue Infections in Bangkok
Burke, D. S., Nisalak, A., Johnson, D. E., & Scott, R. M. (1988) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.172 · Cited by 827 · see citing works
Self-citationDengue: the risk to developed and developing countries.
Monath, T. P. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2395 · Cited by 787 · see citing works
Balkwill, F. R., & Burke, F. (1989) · Immunology Today · doi:10.1016/0167-5699(89)90085-6 · Cited by 785 · see citing works
Dengue haemorrhagic fever: diagnosis, treatment, prevention and control
Crane, G. (1999) · Pathology · doi:10.1016/s0031-3025(16)34854-1 · Cited by 748 · see citing works
Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control
Gould, E. A. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)91100-2 · Cited by 724 · see citing works
Innis, B. L., Nisalak, A., Nimmannitya, S., Kusalerdchariya, S., Chongswasdi, V., Suntayakorn, S., Puttisri, P., & Hoke, C. H. (1989) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1989.40.418 · Cited by 711 · see citing works
Self-citationOrigins of Dengue Type 2 Viruses Associated with Increased Pathogenicity in the Americas
Rico-Hesse, R., Harrison, L. M., Salas, R. A., Tovar, D., Nisalak, A., Ramos, C., Bóshell, J., de Mesa, M. T. R., Nogueira, R. M. R., & da Rosa, A. T. (1997) · Virology · doi:10.1006/viro.1997.8504 · Cited by 681 · see citing works
Self-citationHuman skin Langerhans cells are targets of dengue virus infection
Wu, S.-J. L., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E. F., Putvatana, R., Louder, M. K., Filgueira, L., Marovich, M., Wong, H. K., et al. (2000) · Nature Medicine · doi:10.1038/77553 · Cited by 664 · see citing works
Early Clinical and Laboratory Indicators of Acute Dengue Illness
Kalayanarooj, S., Vaughn, D. W., Nimmannitya, S., Green, S., Suntayakorn, S., Kunentrasai, N., Viramitrachai, W., Ratanachu‐eke, S., Kiatpolpoj, S., Innis, B. L., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514047 · Cited by 651 · see citing works
Self-citationHenchal, E. A., & Putnak, J. R. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.4.376 · Cited by 625 · see citing works
Dengue Virus Structural Differences That Correlate with Pathogenesis
Leitmeyer, K. C., Vaughn, D. W., Watts, D. M., Salas, R., Villalobos, I., de Chacon, Ramos, C., & Rico-Hesse, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4738-4747.1999 · Cited by 617 · see citing works
Self-citationThe Soluble Interleukin-2 Receptor: Biology, Function, and Clinical Application
Rubin, L. A., & Nelson, D. L. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-8-619 · Cited by 602 · see citing works
Halstead, S. B., Nimmannitya, S., & Cohen, S. N. (1970) · PubMed · Cited by 480 · see citing works
Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic Cascade
Halstead, S. B. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.supplement_4.s830 · Cited by 435 · see citing works
Dengue in the Early Febrile Phase: Viremia and Antibody Responses
Vaughn, D. W., Green, S., Kalayanarooj, S., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514048 · Cited by 431 · see citing works
Self-citationPathology of fatal human infection associated with avian influenza A H5N1 virus
To, K., Chan, P. K. S., Chan, K.-F., Lee, W.-K., Lam, W.-Y., Wong, K.-F., Tang, N. L. S., Tsang, D. N. C., Sung, R. Y. T., Buckley, T. A., et al. (2001) · Journal of Medical Virology · doi:10.1002/1096-9071(200103)63:3 · Cited by 422 · see citing works
Green, S., Vaughn, D. W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Lew, R., Innis, B. L., Kurane, I., Rothman, A. L., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314680 · Cited by 372 · see citing works
Self-citationImmunopathogenesis of Dengue Hemorrhagic Fever
Rothman, A. L., & Ennis, F. A. (1999) · Virology · doi:10.1006/viro.1999.9656 · Cited by 371 · see citing works
Self-citationGlobal situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas.
Pinheiro, F. P., & Corber, S. J. (1997) · PubMed · Cited by 325 · see citing works
Kurane, I., Innis, B. L., Nimmannitya, S., Nisalak, A., Meager, A., Janus, J., & Ennis, F. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115457 · Cited by 312 · see citing works
Self-citationHober, D., Poli, L., Roblin, B., et al. (1993) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1993.48.324 · Cited by 284 · see citing works
Infection of Human Cells by Dengue Virus Is Modulated by Different Cell Types and Viral Strains
Diamond, M., Edgil, D., Roberts, T. G., Lu, B., & Harris, E. (2000) · Journal of Virology · doi:10.1128/jvi.74.17.7814-7823.2000 · Cited by 264 · see citing works
Libraty, D. H., Pichyangkul, S., Ajariyakhajorn, C., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.8.3501-3508.2001 · Cited by 254 · see citing works
Self-citationViraemia in patients with naturally acquired dengue infection.
GUBLER, D. J., Suharyono, W., Tan, R., et al. (1981) · PubMed · Cited by 211 · see citing works
Early CD69 Expression on Peripheral Blood Lymphocytes from Children with Dengue Hemorrhagic Fever
Green, S., Pichyangkul, S., Vaughn, D. W., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315072 · Cited by 207 · see citing works
Self-citationSingh, S. K., & Ruzek, D. (2013) · CRC Press eBooks · doi:10.1201/b15172-31 · Cited by 191 · see citing works
Gagnon, S. J., Ennis, F. A., & Rothman, A. L. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3623-3629.1999 · Cited by 189 · see citing works
Self-citationHaematology in dengue and dengue haemorrhagic fever
Srichaikul, T., & Nimmannitya, S. (2000) · Best Practice & Research Clinical Haematology · doi:10.1053/beha.2000.0073 · Cited by 186 · see citing works
Pathophysiologic and Prognostic Role of Cytokines in Dengue Hemorrhagic Fever
Bethell, D. B., Flobbe, K., Phuong, C. X. T., Day, N. P. J., Phuong, P. T., Buurman, W. A., Cardosa, M. J., White, N. J., & Kwiatkowski, D. (1998) · The Journal of Infectious Diseases · doi:10.1086/517807 · Cited by 180 · see citing works
Houng, H. H., Chen, R. C.-M., Vaughn, D. W., et al. (2001) · Journal of Virological Methods · doi:10.1016/s0166-0934(01)00280-4 · Cited by 161 · see citing works
Self-citationElevated levels of IL-8 in dengue hemorrhagic fever
Raghupathy, R., Chaturvedi, U. C., Al-Sayer, H. M., Elbishbishi, E. A., Agarwal, R., Nagar, R., Kapoor, S., MISRA, A., Mathur, A., Nusrat, H., et al. (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199811)56:3 · Cited by 161 · see citing works
Gamble, J., Bethell, D., Day, N. P. J., Loc, P. P., Phu, N. H., GARTSIDE, I. B., Farrar, J. F., & White, N. J. (2000) · Clinical Science · doi:10.1042/cs19990296 · Cited by 152 · see citing works
Murgue, B., Roche, C., Chungue, E., & Deparis, X. (2000) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(200004)60:4 · Cited by 149 · see citing works
Effects of microbes on the immune system
Cunningham, M. W., & Fujinami, R. J. (2000) · Lippincott Williams & Wilkins eBooks · Cited by 146 · see citing works
Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever
Mustafa, A. S., Elbishbishi, E. A., Agarwal, R., et al. (2001) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2001.tb01575.x · Cited by 122 · see citing works
High Levels of Viremia in Patients with the Hantavirus Pulmonary Syndrome
Terajima, M., Hendershot, J. D., Kariwa, H., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315153 · Cited by 117 · see citing works
A phase I clinical trial of recombinant human tumor necrosis factor
Creagan, E. T., Kovach, J. S., Moertel, C. G., Frytak, S., & Kvols, L. K. (1988) · Cancer · doi:10.1002/1097-0142(19881215)62:12 · Cited by 113 · see citing works
Epidemic Dengue Hemorrhagic Fever in Rural Indonesia
GUBLER, D. J., Suharyono, W., Lubis, I., et al. (1979) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1979.28.701 · Cited by 112 · see citing works
Pryor, M. J., Carr, J. M., Hocking, H., Davidson, A. D., Li, P., & Wright, P. J. (2001) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.65.427 · Cited by 111 · see citing works
Moliner, L. D., Pontisso, P., Salvo, G. L. D., et al. (1998) · Gut · doi:10.1136/gut.42.6.856 · Cited by 108 · see citing works
Nutritional Status of Children with Dengue Hemorrhagic Fever
Thisyakorn, U., & Nimmannitya, S. (1993) · Clinical Infectious Diseases · doi:10.1093/clind/16.2.295 · Cited by 97 · see citing works
High Levels of sTNFR p75 and TNFα in Dengue‐Infected Patients
Hober, D., Delannoy, A., Benyoucef, S., et al. (1996) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1996.tb01110.x · Cited by 87 · see citing works
Histocompatibility Antigens and Dengue Hemorrhagic Fever
Chiewsilp, P., Scott, R. M., & Bhamarapravati, N. (1981) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1981.30.1100 · Cited by 83 · see citing works
Antigen capture elisa for the identification of dengue viruses
Kuno, G., Gubler, D. J., & de Weil, N. S. (1985) · Journal of Virological Methods · doi:10.1016/0166-0934(85)90011-4 · Cited by 55 · see citing works
Sosman, J. A., Verma, A. K., Moss, S., Sorokin, P., Blend, M. J., Bradlow, B. A., Chachlani, N., Cutler, D. L., Sabo, R., Nelson, M. F., et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02314.x · Cited by 55 · see citing works
Profile of transforming growth factor‐beta 1 in patients with dengue haemorrhagic fever
Agarwal, Elbishbishi, Chaturvedi, et al. (1999) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.1999.00107.x · Cited by 54 · see citing works
O'Sullivan, M. A., & Killen, H. M. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-9-2387 · Cited by 47 · see citing works
Gorp, E. C. M. V., Minnema, M. C., Suharti, C., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02710.x · Cited by 44 · see citing works
Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy
Clarke, J. R., Braganza, R., Mirza, A., Stainsby, C. M., Ait‐Khaled, M., Wright, A., Lyall, H., Parker, D., McClure, M. O., Weber, J. N., et al. (1999) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199911)59:3 · Cited by 44 · see citing works
Rigau-Pérez, J. G., & Bonilla, G. (1999) · PubMed · Cited by 40 · see citing works
Thrombocytopenia and complement activation under recombinant TNFα/IFNγ therapy in man
Michelmann, I., BÖCKMANN, D., Nürnberger, W., et al. (1997) · Annals of Hematology · doi:10.1007/s002770050279 · Cited by 30 · see citing works
An Evaluation of Modified Case Definitions for the Detection of Dengue Hemorrhagic Fever
Rigau-Pérez, J. G., & Bonilla, G. (2014) · Puerto Rico health sciences journal · Cited by 16 · see citing works
Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever
Mustafa, A. M. (2001) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(01)00227-9 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 5
- Huang YH, Liu CC, Wang ST, et al. Activation of coagulation and fibrino- lysis during dengue virus infection. J Med Virol 2001; 63:247-51.
- Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba. Am J Trop Med Hyg 1990; 42:179-84.
- Sudiro TM, Zivny J, Ishiko H, et al. Analysis of plasma viral RNA levels during acute dengue virus infection using quantitative competitor re- verse transcription-polymerase chain reaction. J Med Virol 2001; 63: 29-34.
- Green S, Vaughn DW, Kalayanarooj S, et al. Elevated plasma interleukin- 10 levels in acute dengue correlate with disease severity. J Med Virol 1999; 59:329-34.
- Kurane I, Innis BL, Nimmannitya S, et al. Activation of T lymphocytes in dengue virus infections. J Clin Invest 1991; 88:1473-80.
Cited by
Sorted by citations
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940 · see citing works
Whitehorn, J., & Simmons, C. P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.022 · Cited by 282 · see citing works
- Authors
- Libraty, D. H., Endy, T. P., Houng, H. H., Green, S., Kalayanarooj, S., Suntayakorn, S., Chansiriwongs, W., Vaughn, D. W., Nisalak, A., Ennis, F. A., & Rothman, A. L.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Armed Forces Research Institute of Medical Science (TH)
- Walter Reed Army Institute of Research (US)
- Queen Sirikit National Institute of Child Health (TH)
- Kamphaeng Phet Hospital (TH)
- Corresponding author
- Libraty, Daniel H.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05
- Volume
- 185
- Issue
- 9
- Pages
- 1213-1221
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2110628545
- Cited by
- 494
- References
- 60
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 9 · 2023: 13 · 2022: 7 · 2021: 15 · 2020: 27 · 2019: 16 · 2018: 13 · 2017: 27 · 2016: 29 · 2015: 35 · 2014: 37 · 2013: 27 · 2012: 35
- FWCI
- 13.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI-34533, P01AI034533)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Keywords
- dengue hemorrhagic fever, secondary dengue infection, disease severity, plasma viremia, immune activation, interferon-gamma, IL-10, soluble tumor necrosis factor receptor II, soluble interleukin-2 receptor, thrombocytopenia, plasma leakage, hepatic transaminase elevation, Th1 cytokines, children
- MeSH terms
- Child, Female, Humans, Interferon-gamma, Male, Prospective Studies, Viremia, Antigens, CD, Multivariate Analysis, Interleukin-10, DNA, Complementary, Receptors, Tumor Necrosis Factor, Viral Load, Severe Dengue, Reverse Transcriptase Polymerase Chain Reaction, Receptors, Tumor Necrosis Factor, Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review